retatrutide patent expiration The upcoming expiry of the semaglutide in India in mid-March 2026 is expected to transform the country's diabetes treatment landscape. Ahead of this, industry experts predict that the development will open Pharma Competitive Intelligence in One

Semaglutide is contraindicated in patients with: Personal or family history of medullary thyroid carcinoma (MTC) Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) Common Adverse Effects According to clinical trial data, gastrointestinal effects are most frequently reported: nausea, vomiting, diarrhea, constipation, and abdominal discomfort

Before After At the age of 60, I look and feel better than I ever have in my entire life

[1] [2] These symptoms typically occur during dose initiation or escalation and often improve over time as the body adjusts to the medication

Our focus on providing the latest advancements in healthcare means that, if approved, retatrutide, may be one of the most advanced options available at the biostation if you're seeking an effective, long-term weight loss solution

Managing Skin Sensitivity During Treatment Rotating injection sites, using fragrance-free emollients, and applying broad-spectrum SPF 30+ sunscreen are first-line measures